PTPN13 and chronic myelogenous leukemia, BCR-ABL1 positive: The PTPN13 gene encodes the PTPN13, which is a negative regulator of tumor growth in human breast and ovarian cancer [20], but its pathological role in CML and tumor sensitivity in tyrosine kinase inhibitors are not known.